That's why I wanted to see if it is officially listed in the trial design. FDA knows what they accepted as secondary endpoint. Cytodyn has said clearly that they got SS in this, gave p values. So, let's see who is in the wrong. FDA has to correct the error or Cytodyn has to explain why not.
News 
Market Data 
Discover 
